However, tumor cells often downregulate their MHC-I molecule expression to evade the attack of CD8+ cytotoxic T cells, as the target recognition of CD8+ T cells relies on antigen presentation by MHC-I [44, 45]. The gene discussed is CD8A; the disease is neoplasm.